Correlation Between Zenith Capital and NewAmsterdam Pharma
Can any of the company-specific risk be diversified away by investing in both Zenith Capital and NewAmsterdam Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zenith Capital and NewAmsterdam Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zenith Capital Corp and NewAmsterdam Pharma, you can compare the effects of market volatilities on Zenith Capital and NewAmsterdam Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zenith Capital with a short position of NewAmsterdam Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zenith Capital and NewAmsterdam Pharma.
Diversification Opportunities for Zenith Capital and NewAmsterdam Pharma
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Zenith and NewAmsterdam is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Zenith Capital Corp and NewAmsterdam Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewAmsterdam Pharma and Zenith Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zenith Capital Corp are associated (or correlated) with NewAmsterdam Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewAmsterdam Pharma has no effect on the direction of Zenith Capital i.e., Zenith Capital and NewAmsterdam Pharma go up and down completely randomly.
Pair Corralation between Zenith Capital and NewAmsterdam Pharma
Assuming the 90 days horizon Zenith Capital Corp is expected to generate 53.87 times more return on investment than NewAmsterdam Pharma. However, Zenith Capital is 53.87 times more volatile than NewAmsterdam Pharma. It trades about 0.19 of its potential returns per unit of risk. NewAmsterdam Pharma is currently generating about 0.04 per unit of risk. If you would invest 13.00 in Zenith Capital Corp on August 29, 2024 and sell it today you would lose (2.00) from holding Zenith Capital Corp or give up 15.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zenith Capital Corp vs. NewAmsterdam Pharma
Performance |
| Timeline |
| Zenith Capital Corp |
| NewAmsterdam Pharma |
Zenith Capital and NewAmsterdam Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zenith Capital and NewAmsterdam Pharma
The main advantage of trading using opposite Zenith Capital and NewAmsterdam Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zenith Capital position performs unexpectedly, NewAmsterdam Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewAmsterdam Pharma will offset losses from the drop in NewAmsterdam Pharma's long position.The idea behind Zenith Capital Corp and NewAmsterdam Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| NewAmsterdam Pharma vs. Eliem Therapeutics | NewAmsterdam Pharma vs. Scpharmaceuticals | NewAmsterdam Pharma vs. Milestone Pharmaceuticals | NewAmsterdam Pharma vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |